Arbutus Reports First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
*End-of-treatment data from two Phase 2a combination clinical trials with imdusiran to be presented at the EASL Congress in June..
*End-of-treatment data from two Phase 2a combination clinical trials with imdusiran to be presented at the EASL Congress in June..
HONG KONG SAR - Media OutReach - 21 November 2023 - *BODW City Programme (CityProg)* is the 'beyond the main stage' Hong Kong..
*The 2nd World Frontier Science and Technology Conference (Hong Kong Branch) will Open in Hong Kong June 2023*
HONG..